BALTIMORE, MD, UNITED STATES, August 6, 2026 /EINPresswire.com/ — Linshom Medical announced today that it has been awarded a $100,000 Phase 2 grant from the Maryland Industrial Partnerships (MIPS) program to support an interventional clinical trial of its respiratory monitoring device, led by faculty from the University of Maryland School of Medicine (UMSOM).
“This clinical trial is an extension of a Phase 1 clinical study completed last year and will evaluate the device’s ability to drive early intervention of patient respiratory decline in the Post Anesthesia Care Unit (PACU),” said Donald R. Herdt, MD, MBA, principal investigator and assistant professor of anesthesiology at UMSOM. “The Phase 1 study demonstrated the device’s ability to detect respiratory depression episodes (RDEs) 25 minutes before current standard of care. Now, we will measure the effect of early intervention.”
“Current standard of care and existing technology provide warnings after a patient is in respiratory trouble,” said Richard Hughen, chief executive officer of Linshom Medical. “If we are able to provide early or predictive notice of respiratory decline, health care providers should be able to intervene and avoid costly events like rapid response activations, rescue events (codes), and intensive care unit transfers.”
MIPS provides matching grants for collaborative research projects between Maryland-based companies and University System of Maryland institutions. The grants are awarded on a competitive basis and are based on proposals submitted jointly by participating companies and university researchers.
About Linshom Medical, Inc.
Linshom Medical is first to deliver an AI enabled, wearable, FDA cleared, operating room quality respiratory profile to the patient bedside providing early warning of respiratory problems and avoiding costly rapid response activations, rescue events (codes), ICU transfers and deaths. The patented device provides a predictive (vs. responsive) respiratory profile including Respiratory Rate (RR), relative Tidal Volume (rVt) and Seconds Since Last Breath (SSLB) that are all delivered continuously and in real time. Our mission is to eliminate the morbidity, mortality and cost due to unrecognized respiratory compromise in healthcare. For more information, visit www.LinshomMedical.com.
About Maryland Industrial Partnerships (MIPS)
The Maryland Industrial Partnerships (MIPS) program is an initiative of the Maryland Technology Enterprise Institute (Mtech) in the A. James Clark School of Engineering at the University of Maryland. MIPS funds university research projects that team faculty with Maryland-based companies to develop technology products and processes. Both the company and MIPS provide funds for each project. All funds go to the university researchers. www.mips.umd.edu
Richard Hughen
Linshom Medical, Inc.
email us here
Visit us on social media:
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
